Novo Nordisk shares jumped nearly 8% on Tuesday after the U.S. Food and Drug Administration approved its weight-loss pill, ...

Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market ...

Explore the transformation of weight-loss drugs with the rise of GLP-1 pills, the impact of telehealth, and consumer-driven ...

Relief rally underway in Novo Nordisk after a difficult year for the stock which saw it lose ground to arch-competitor Eli ...

The U.S. Food and Drug Administration has approved Novo Nordisk’s Wegovy® pill, making it the first and only oral GLP-1 ...

The FDA approved Novo Nordisk’s once-daily Wegovy pill, making it the first oral GLP-1 weight loss drug to reach the U.S.

Novo Nordisk shares jumped nearly eight per cent on Tuesday after the U.S. Food and Drug Administration approved its ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Pedersen and Bhanvi Satija LONDON/COPENHAGEN, Dec 23 (Reuters) - Novo Nordisk secured U.S. regulatory approval for its weight ...

A defence analyst tells the ABC an attack on the Russian President's state residence would be "technically" possible but ...